IVD News
Search and Filter
Results per Page:
A promising HIV vaccine candidate gets a little help
New strategy stirs a robust response from T cells tracked by McElrath lab
Early research may show new way to block dengue and Zika virus
Scientists find different flavor of broadly neutralizing antibody that could lead to new vaccines for growing threat
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
Could a 100-year-old TB vaccine help scientists find a better one?
Harmless vaccine BCG is made of living bacteria; in tests might serve as a proxy for deadly tuberculosis
On World AIDS Day, a broad view of continuing work
Teams of Fred Hutch scientists test vaccines, treatments, new strategies
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation
NIAID director’s determined spirit recognized with honorary Hutch Award
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Researchers advance development of potential Epstein-Barr virus vaccines
Stakes raised as common virus linked to more diseases
Test of a new 'germline-targeting' HIV vaccine prepares to launch
Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus
Solid tumors use a type of T cell as a shield against immune attack
Discovery in head and neck cancers may open door for targeted immune-boosting drugs
Tackling the unknowns of long-haul COVID-19
Fred Hutch and UW researchers are working together to better understand and treat the syndrome
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
Sleuthing the immune system’s mysterious T-regs
Dr. Jennifer Lund probes why regulatory T cells show up when trouble comes around
Using AI to identify potential COVID-19, cancer therapies
Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
New open source software empowers scientists to uncover immune secrets
'Infinity Flow’ adds machine learning to widespread, but limited, technology for analyzing single cells
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
Addressing a 'massive unmet need' in COVID-19 treatment
COVID-19 Clinical Research Center tests drugs to reduce severe infections
Hutch researchers discover neutralizing antibodies to parainfluenza
New hope for transplant patients vulnerable to this common respiratory virus
Natural protection from COVID-19 gets boost from a single dose of vaccine
Tests of patients' blood show vaccine stirs antibodies against variants and 2003 SARS virus
Biostatisticians draft blueprints for COVID-19 vax trials
Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic